Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

The Total Lifetime Cost of Treating Patients (Pts) with CLL in the United States (US)

Farrukh T. Awan, Aleksandra Vidisheva, Matia Saeedian, Murat Kurt, Simran K. Tiwana, Masoom Priyadarshini

Blood (2023) 142 (Supplement 1): 2330.

https://doi.org/10.1182/blood-2023-178058

Published: 2023

Journal Articles

Health Care Resource Utilization (HCRU) and Cost of Management of Cytokine Release Syndrome (CRS) and Neurological Events (NEs) in Patients with R/R CLL/SLL Receiving Lisocabtagene Maraleucel (liso-cel) Treatment in the TRANSCEND CLL 004 Study

Farrukh T. Awan, November McGarvey, Abraham Lee, Ken Imanak, Simran K. Tiwana, Sean Garrison, Masoom Priyadarshini

Blood (2023) 142 (Supplement 1): 7252.

https://doi.org/10.1182/blood-2023-178048

Published: 2023

Journal Articles

Real-World Treatment (Tx) Patterns and Clinical Outcomes Among Patients (Pts) with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Who Received at Least 2 Prior Lines of Therapy Including Bruton Tyrosine Kinase Inhibitor (BTKi) and/or B-Cell Lymphoma 2 Inhibitor (BCL2i)

Farrukh T. Awan, Gaurav A. Deshpande, Trong Kim Le, Sean Garrison, Simran K. Tiwana, Masoom Priyadarshini

Blood (2022) 140 (Supplement 1): 7028–7029.

https://doi.org/10.1182/blood-2022-159195

Published: 2022